Resultats de la cerca - Emmanuelle Crinière
- Mostrar 1 - 4 resultats de 4
-
1
Prognostic impact of molecular markers in a series of 220 primary glioblastomas per Caroline Houillier, Julie Lejeune, Alexandra Benouaich‐Amiel, Florence Laigle–Donadey, Emmanuelle Crinière, Karima Mokhtari, Joëlle Thillet, Jean‐Yves Delattre, Khê Hoang‐Xuan, Marc Sanson
Publicat 2006Artigo -
2
A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases per Sophie Camilleri‐Bröet, Emmanuelle Crinière, Philippe Broët, Vincent Delwail, Karima Mokhtari, Anne Moreau, M. Kujas, Martine Raphaël, Wafae Iraqi, Catherine Sautès‐Fridman, Philippe Colombat, Khê Hoang‐Xuan, Antoine Martin
Publicat 2005Artigo -
3
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas per Sibille Everhard, Jörg Tost, Hafida El abdalaoui, Emmanuelle Crinière, Florence Busato, Yannick Marie, Marta Gut, Marc Sanson, Karima Mokhtari, Florence Laigle–Donadey, Khê Hoang‐Xuan, Jean‐Yves Delattre, Joëlle Thillet
Publicat 2009Artigo -
4
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions per Khê Hoang‐Xuan, L. Capelle, M. Kujas, Sophie Taillibert, Hugues Duffau, Julie Lejeune, M. Polivka, Emmanuelle Crinière, Y. Marie, Karima Mokhtari, Alain Carpentier, F. Laigle, Julien Simon, Philippe Cornu, Philippe Broët, Marc Sanson, J. Delattre
Publicat 2004Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer research
Gene
Medicine
Pathology
Allele
Genetics
Glioma
Internal medicine
Loss of heterozygosity
Oncology
Temozolomide
Antibody
Astrocytoma
B cell
Biochemistry
Bisulfite sequencing
CDKN2A
CDKN2B
Cancer
Carcinogenesis
Central nervous system
Chemistry
Chemotherapy
Chromosome
CpG site
DNA methylation
DNA methyltransferase
Disease
Exon